Strong gains from low-risk acquisitions

Article Excerpt

MCKESSON CORP. $87 (New York symbol MCK; Aggressive Growth Portfolio, Consumer sector; Shares outstanding: 246.1 million; Market cap: $21.4 billion; Price-to-sales ratio: 0.2; Dividend yield: 0.9%; TSINetwork Rating: Above Average; www.mckesson.com) is the largest wholesale drug distributor in the U.S. and Canada. It also owns 49% of Mexico’s largest drug distributor. McKesson’s customers include 40,000 pharmacies, as well as doctor’s offices, hospitals and clinics. The company also supplies surgical tools and health and beauty products. McKesson’s revenue rose 20.6%, from $93.0 billion in 2007 to $112.1 billion in 2011 (fiscal years end March 31). Earnings jumped 45.2%, from $881 million in 2007 to $1.3 billion in 2011. Because of fewer shares outstanding, earnings per share shot up 68.2%, from $2.89 in 2007 to $4.86 in 2011. Small division earns big profits A big part of the company’s growth comes from its technology solutions division, which makes computers and software that help pharmacies and clinics manage their drug inventories. This division accounts for just 3%…